PoS - Proceedings of Science
Volume 414 - 41st International Conference on High Energy physics (ICHEP2022) - Poster Session
The Laser-hybrid Accelerator for Radiobiological Applications (LhARA)
K.R. Long*, J. McGarrigle and  On behalf of the LhARA collaboration
Full text: pdf
Pre-published on: January 31, 2023
Published on: June 15, 2023
The `Laser-hybrid Accelerator for Radiobiological Applications', LhARA, is conceived as a uniquely flexible international facility dedicated to the study of a completely new regime of radiobiology. The ambition of the multidisciplinary collaboration is that the technologies demonstrated in LhARA will be transformative in the delivery of ion beam therapy.

The laser-hybrid approach offers enormous potential by providing a more flexible, compact, and cost-effective high-energy particle source while evading the space-charge limitations of current sources. LhARA uses a high-power laser to generate an ultrashort burst of protons or light ions from a target. These are captured using strong-focusing electron-plasma (Gabor) lenses at energies up to 15 MeV, enabling ultra-high instantaneous dose rates of up to $10^9$ Gy/s in pulses as short as 10--40\,ns. Further acceleration up to 127 MeV is facilitated by a fixed-field alternating-gradient accelerator designed to accommodate the source flexibility. Measuring the extremely high flux, low energy proton and ion beams at LhARA presents significant challenges. Novel techniques such as beam-gas curtain profile monitors and ion-acoustic dose-profile monitors are being developed for use in proof-of-principle systems. The status of the LhARA project in the context of the Ion Therapy Research Facility recently funded by UKRI will be described along with the LhARA collaboration's vision for the development of a transformative proton- and ion-beam system.
DOI: https://doi.org/10.22323/1.414.1124
How to cite

Metadata are provided both in "article" format (very similar to INSPIRE) as this helps creating very compact bibliographies which can be beneficial to authors and readers, and in "proceeding" format which is more detailed and complete.

Open Access
Creative Commons LicenseCopyright owned by the author(s) under the term of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.